Jihong P. Liu
Union Hospital
Wuhan, 430022, China
Wuhan, 430022, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 246 publications
Guanxinning Tablet Ameliorates Erectile Dysfunction in Diabetes Mellitus Rats with Involvement of PI3K/Akt/FOXO1 Signaling Pathway Modulation.
Journal: Biomedicines
Published: July 14, 2026
Slit2/Robo Signaling Restores Diabetic Erectile Function via Neurovascular Remodeling.
Journal: Andrology
Published: March 28, 2026
Correction: Sun et al. Engineered Adipose-Derived Stem Cells Overexpressing RXFP1 via CRISPR Activation Ameliorate Erectile Dysfunction in Diabetic Rats. Antioxidants 2023, 12, 171.
Journal: Antioxidants (Basel, Switzerland)
Published: February 12, 2026
Luteolin prevents hyperoxaluria-induced renal injury by inhibiting crystal deposition and renal inflammation.
Journal: The international journal of biochemistry & cell biology
Published: September 14, 2025
Exploration of oxidative stress-related molecular signature for clear cell renal cell carcinoma.
Journal: Discover oncology
Published: August 30, 2025
Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation.
Journal: Molecular biomedicine
Published: August 23, 2025
N-Homocysteinylation of HMGB1/2 Promotes Corpus Cavernosum Endothelial Senescence in Erectile Dysfunction.
Journal: International journal of biological sciences
Published: June 13, 2025
Targeting Itga8 Mitigates Neurogenic Bladder Fibrosis Driven by Trem2⁺ Macrophage-Derived Fn1 via FAK/RhoA/ROCK Signaling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 10, 2025
Therapeutic Effect of Micro-Energy Treatment for Erectile Dysfunction: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials.
Journal: The world journal of men's health
Published: April 29, 2025
The SHA.LIN renal stone scoring system for predicting stone-free status and postoperative outcomes after percutaneous nephrolithotomy.
Journal: Frontiers in surgery
Published: March 18, 2025
Apolipoprotein E promotes primary resistance to AR-targeted therapy via inducing TRIM25-mediated AR ubiquitination and sensitizes immunotherapy in prostate cancer.
Journal: Theranostics
Published: January 07, 2025
Last Updated: 09/26/2026